Life sciences businesses have accelerated their digital-first journey to survive and thrive in a world where time-to-everything matters more than any other strategic imperative, according to our study.
Digital ways of working and doing business forged and hammered in the COVID-19 crucible will not be scrapped.
From vaccine testing and production to care access and delivery, every facet of the industry had to adapt at speed and scale. New ways of working (remotely), new ways of doing business (all online) and new ways of creating value (safe customers and employees) made life sciences companies realize just what digital had to offer. In the post-COVID-19 era, “digital” will mean more than just applying technology to business processes; it will mean reinventing the business by connecting data, knowledge, people and insights, turning traditional life sciences into a proactive industry.
For more details, download White Paper here: